Proprio Vision

Originally published by ORTHOWORLD. October 21, 2020.

Proprio is a technology company that combines physician expertise with immersive, intelligent technology to predict and perform surgery.

Proprio is a technology company that combines physician expertise with immersive, intelligent technology to support predicting, performing, and perfecting surgery.

Proprio received FDA clearance for Picasso, the fourth cleared capability within its Paradigm AI surgical platform. The feature enables trace-based optical registration so spine surgeons can take real-time three-dimensional measurements of spinal alignment intraoperatively without repeated X-ray exposure.

Jan 2026 · HIT ConsultantNews article

Proprio forms a distribution partnership with LifeHealthcare to bring its Paradigm AI surgical guidance platform to Australia and New Zealand. LifeHealthcare is an EBOS Group subsidiary, and later phases are planned for Southeast Asia. Proprio CEO and co-founder Gabriel Jones describes the agreement as expanding global access to the system.

Jan 2025 · AiThorityNews article

Proprio develops Paradigm, a guidance device that tracks patient anatomy in real time during spinal surgery. The system combines a multi-sensor light field imaging array with computer vision and captures a surgical dataset. The company has FDA clearance and announces new funding.

Jul 2023 · TechCrunchNews article

Proprio raises $43 million in Series B funding to support commercialization of its AI-driven Paradigm surgical navigation platform. The proceeds are earmarked to accelerate commercialization in the United States and overseas, and the article reports that Paradigm received FDA 510(k) clearance during 2023.

Jul 2023 · FinSMEsNews article